91 related articles for article (PubMed ID: 25150312)
1. Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
Yan Y; Zhang F; Fan Q; Li X; Zhou K
Neoplasma; 2014; 61(6):672-9. PubMed ID: 25150312
[TBL] [Abstract][Full Text] [Related]
2. Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements.
Wu G; Ji Z; Li H; Lei Y; Jin X; Yu Y; Sun M
Cell Biochem Funct; 2014 Oct; 32(7):547-56. PubMed ID: 25132116
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
Xiao F; Chen J; Lian C; Han P; Zhang C
Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
[TBL] [Abstract][Full Text] [Related]
4. microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer.
Zhao Y; Li Y; Wang L; Yang H; Wang Q; Qi H; Li S; Zhou P; Liang P; Wang Q; Li X
J Exp Clin Cancer Res; 2013 Feb; 32(1):10. PubMed ID: 23442927
[TBL] [Abstract][Full Text] [Related]
5. MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells.
Huo W; Jin N; Fan L; Wang W
Mol Cell Biochem; 2014 Mar; 388(1-2):123-33. PubMed ID: 24292881
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.
Liu J; Ma L; Li C; Zhang Z; Yang G; Zhang W
Mol Oncol; 2013 Dec; 7(6):1043-55. PubMed ID: 24001901
[TBL] [Abstract][Full Text] [Related]
7. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.
Zhou K; Yan Y; Zhao S
Tumour Biol; 2014 Jun; 35(6):5787-95. PubMed ID: 24659424
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.
Bo Y; Guo G; Yao W
J Neurooncol; 2013 Mar; 112(1):27-37. PubMed ID: 23338605
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.
Zhang Z; Zhang H; Li H; Chen X; Liu M; Liu D; Zhao Y; Kong X
Mol Cell Biochem; 2014 Jul; 392(1-2):125-34. PubMed ID: 24788726
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
11. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
12. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
13. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
14. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
15. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
Kim DR; Park MY; Lee CS; Shim SH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
Cancer Gene Ther; 2011 Jul; 18(7):467-77. PubMed ID: 21455254
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
17. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
18. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
19. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
Zhou Y; Song X; Jia R; Wang H; Dai L; Xu X; Gu P; Ge S; Fan X
Pigment Cell Melanoma Res; 2010 Oct; 23(5):661-74. PubMed ID: 20546535
[TBL] [Abstract][Full Text] [Related]
20. The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells.
Yao W; Guo G; Zhang Q; Fan L; Wu N; Bo Y
Virology; 2014 Jun; 458-459():69-82. PubMed ID: 24928040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
